
CervoMed fell 79.3% from $6.90 to $1.43, behind the S&P 500's +10.5%. Its worst day was Jun 10 (−22.1%), and its low came Nov 6 at $1.42.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.84 missed the $-0.61 estimate on $322,569.00 revenue (est. $1.1M).
0.0% · S&P 500 +1.6%
CervoMed closed at its highest level of the year, 44.1% above where the year started.
Story events cover the past 12 months · Times ET
+3.3% · S&P 500 +0.7%
EPS of $-0.88 missed the $-0.69 estimate on $8.7M revenue (est. $329,998.00).
+5.1% · S&P 500 +0.3%
EPS of $-0.86 missed the $-0.81 estimate on $0.00 revenue (est. $90,000.00).
−8.5% · S&P 500 −1.2%
CervoMed shares rose 82.3%, while the S&P 500 fell 0.6%.
+82.3%, the year's best day, on 201M shares, the year's heaviest volume · S&P 500 −0.6%
CervoMed shares rose 19.0%, while the S&P 500 fell 0.1%.
+19.0% · S&P 500 −0.1%
EPS of $-0.64 beat the $-0.87 estimate on $0.00 revenue (est. $140,000.00).
−0.3% · S&P 500 0.0%
CervoMed shares fell 22.0%, while the S&P 500 fell 0.1%.
−22.0% · S&P 500 −0.1%
CervoMed shares fell 20.8%, while the S&P 500 fell 0.4%.
−20.8% · S&P 500 −0.4%
EPS of $-0.39 beat the $-0.52 estimate on $0.00 revenue (est. $100,000.00).
−2.1% · S&P 500 +0.3%
Where it ended: a close of $1.43 on Nov 9, 2026.
Nothing in the past 12 months.
All CRVO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CRVO and SPY from Benzinga historical bars. Not investment advice.